Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robson Lima

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Revista Brasileira De Medicina Do Trabalho : Publicacao Oficial Da Associacao Nacional De Medicina Do Trabalho-Anamt|April 27, 2023
Toluene: correlation between occupational exposure limits and biological exposure indicesAldrin Robson Lima
Journal of Asthma and Allergy|July 8, 2021
Characteristics of Treated Asthmatics Experiencing Exacerbations in a US Database: A Retrospective Cohort StudyCarlyne M Averell, David Hinds, Jolyon Fairburn-Beech, et al.
Peerj. Computer Science|February 3, 2022
Towards ubiquitous requirements engineering through recommendations based on context historiesRobson Lima, Alexsandro S Filippetto, Wesllei Heckler, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 9, 2021
Treatment Patterns and Disease Burden Associated with Multiple-Inhaler Triple-Therapy Use in AsthmaJohn Oppenheimer, Michael Bogart, Lindsay G S Bengtson, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 10, 2021
Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort studyCarlyne M Averell, François Laliberté, Guillaume Germain, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 2, 2021
Real-world evidence: Patient views on asthma in respiratory specialist clinics in AmericaJohn Oppenheimer, David J Slade, Beth A Hahn, et al.
Chest|October 8, 2020
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment TrialNicola A Hanania, David M Mannino, Gerard J Criner, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Revista Brasileira De Medicina Do Trabalho : Publicacao Oficial Da Associacao Nacional De Medicina Do Trabalho-Anamt|April 27, 2023
Toluene: correlation between occupational exposure limits and biological exposure indicesAldrin Robson Lima
Journal of Asthma and Allergy|July 8, 2021
Characteristics of Treated Asthmatics Experiencing Exacerbations in a US Database: A Retrospective Cohort StudyCarlyne M Averell, David Hinds, Jolyon Fairburn-Beech, et al.
Peerj. Computer Science|February 3, 2022
Towards ubiquitous requirements engineering through recommendations based on context historiesRobson Lima, Alexsandro S Filippetto, Wesllei Heckler, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 9, 2021
Treatment Patterns and Disease Burden Associated with Multiple-Inhaler Triple-Therapy Use in AsthmaJohn Oppenheimer, Michael Bogart, Lindsay G S Bengtson, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 10, 2021
Symptom control in patients with asthma using inhaled corticosteroids/long-acting β<sub>2</sub>-agonists (fluticasone furoate/vilanterol or budesonide/formoterol) in the US: a retrospective matched cohort studyCarlyne M Averell, François Laliberté, Guillaume Germain, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|January 2, 2021
Real-world evidence: Patient views on asthma in respiratory specialist clinics in AmericaJohn Oppenheimer, David J Slade, Beth A Hahn, et al.
Chest|October 8, 2020
Effect of Age on the Efficacy and Safety of Once-Daily Single-Inhaler Triple-Therapy Fluticasone Furoate/Umeclidinium/Vilanterol in Patients With COPD: A Post Hoc Analysis of the Informing the Pathway of COPD Treatment TrialNicola A Hanania, David M Mannino, Gerard J Criner, et al.
Pageof 1